Hryz Bio Tech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 300

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 12

Hryz Bio Tech General Information

Description

Manufacturer of immunotherapy products intended for the biopharmaceutical and oncology industries. The company's offerings include multi antigen autologous immune cell therapies, TCR T cell products, TCR bispecific antibodies, GMPcompliant cell preparation services and clinical stage immunotherapy development, enabling targeted and differentiated immune based treatment options for cancer patients.

Contact Information

Website
www.shhryz.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Number 199, Guangfulin East Road
  • Songjiang District
  • Shanghai, 201600
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Number 199, Guangfulin East Road
  • Songjiang District
  • Shanghai, 201600
  • China
+86 021

Hryz Bio Tech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hryz Bio Tech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hryz Bio Tech‘s full profile, request access.

Request a free trial

Hryz Bio Tech Patents

Hryz Bio Tech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019196087-A1 Methods of cancer treatment using tumor antigen-specific t cells Inactive 13-Apr-2018
JP-2024069663-A Methods of obtaining tumor-specific t cell receptors Pending 13-Apr-2018
WO-2019196088-A1 Methods of obtaining tumor-specific t cell receptors Inactive 13-Apr-2018
WO-2019183924-A1 Improved multiple antigen specific cell therapy methods Inactive 30-Mar-2018
WO-2019185041-A1 Improved multiple antigen specific cell therapy methods Inactive 30-Mar-2018 C12N5/0638
To view Hryz Bio Tech’s complete patent history, request access »

Hryz Bio Tech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hryz Bio Tech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hryz Bio Tech‘s full profile, request access.

Request a free trial

Hryz Bio Tech FAQs

  • When was Hryz Bio Tech founded?

    Hryz Bio Tech was founded in 2015.

  • Where is Hryz Bio Tech headquartered?

    Hryz Bio Tech is headquartered in Shanghai, China.

  • What is the size of Hryz Bio Tech?

    Hryz Bio Tech has 300 total employees.

  • What industry is Hryz Bio Tech in?

    Hryz Bio Tech’s primary industry is Drug Discovery.

  • Is Hryz Bio Tech a private or public company?

    Hryz Bio Tech is a Private company.

  • What is Hryz Bio Tech’s current revenue?

    The current revenue for Hryz Bio Tech is .

  • How much funding has Hryz Bio Tech raised over time?

    Hryz Bio Tech has raised $43M.

  • Who are Hryz Bio Tech’s investors?

    Cybernaut Investment (China), Shanghai Shengdi Private Equity Fund Management, Yunion Healthcare Ventures, China Science & Merchants Investment Management Group, and HSG (Hong Kong) are 5 of 15 investors who have invested in Hryz Bio Tech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process